What the business is, and whether it's a good one at a fair price.
Manufactures and exports dental products for clinics, dental laboratories and OEMs, with a product range spanning endodontic files (Rotoflex), oral-care items (Oradox), 3D-printing resins, Omni-branded 3D printers, and a newly commercialised disinfectant line for dental and medical settings. Revenue of INR 71.81 crore in FY26 grew 13.9% year-on-year, with exports contributing the larger share and rising 17.58% across 90-92 countries; the US subsidiary Axiodent grew 37.58% via private-label and direct sales. Domestic sales rose 9%, weighed in H1 by GST changes and Jammu floods before recovering in H2. Digital dentistry (3D printers and resins) is the priority growth area, with 3D-printer unit sales up 162% and resin volumes up 40.5%; a fully indigenous 3D printer is targeted by 2028. The company operates through three subsidiaries (Denvisio Biomed in India, Axiodent in the US, and the newly formed Prevest Denpro Gulf in the UAE for Dubai-based import/export and trading) and supplies 3-4 large multinational OEMs.
Measured from the filed financials, judged against its Medical Equipment & Supplies peers · as of FY26 — not investment advice
How has the market priced it — with filings on the timeline?
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
How does it stack up on valuation, returns and growth?
Loading peers…
Quarterly & annual P&L, balance sheet, cash flow, ratios and segments.
Loading financials…
Who owns it — and is the promoter stake clean?
Loading shareholding…
Sign up to see the full company file
Governance, sustainability, compliance, earnings calls, presentations, events, reactions and the full filings feed — free with an account.
Answered from Prevest Denpro Limited's filed financials and exchange disclosures
Prevest Denpro Limited is a Healthcare Equipment & Supplies company listed on BSE.
Yes. The dividend yield is 0.25% at the current price.
Effectively yes. It holds ₹73 Cr more cash than debt.
On trailing P/E, Prevest Denpro Limited ranks 8 of 17 in Medical Equipment & Supplies — cheaper than 56% of them, against an industry median of 20.0×. This is a position, not a valuation judgement.
On a typical session Prevest Denpro Limited moves 1.51% — that is the median absolute close-to-close move across its last 266 trading days. Announcement days are routinely larger.
Every NSE and BSE filing by Prevest Denpro Limited appears on this page, AI-summarised, alongside the price reaction that followed it. Follow the company to get each new filing on WhatsApp within minutes.
Figures are as last reported and may lag the latest filing. Not investment advice.
